Opportunity Information: Apply for CDC RFA PS15 150102CONT16
Apply for CDC RFA PS15 150102CONT16
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Tuberculosis Elimination and Laboratory Cooperative Agreement" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.116 Project Grants and Cooperative Agreements for Tuberculosis Control Programs.
- This funding opportunity was created on Jul 1, 2015 and posted on Jul 1, 2015.
- Applicants must submit their applications by Aug 31, 2015. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 50 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- This award will be a continuation of funds intended only for grantees previously awarded under PS15 1501, Tuberculosis Elimination and Laboratory Cooperative Agreement.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Tuberculosis Elimination and Laboratory Cooperative Agreement (Funding Opportunity Number CDC RFA PS15-150102CONT16) is a Centers for Disease Control and Prevention (CDC) continuation funding opportunity administered through the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. It sits within the health funding activity category and uses a cooperative agreement as the funding instrument, which generally means the CDC expects to have substantial involvement with recipients in carrying out the supported work (for example, through collaboration, technical guidance, shared planning, or coordinated implementation), rather than operating as a hands-off grant.
This particular announcement is explicitly a continuation of funds tied to the earlier opportunity PS15-1501, titled "Tuberculosis Elimination and Laboratory Cooperative Agreement." In practical terms, that means the eligible applicant pool is restricted: it is intended only for organizations that were already funded under PS15-1501 and are continuing the same line of CDC-supported TB elimination and laboratory activities. The listing shows eligible applicants as "Others (see text field entitled Additional Information on Eligibility for clarification)," but the eligibility statement removes ambiguity by clarifying that new applicants are not the target for this continuation action.
The program aligns with the CDCs core public health mission in tuberculosis control and elimination, including the laboratory capacity needed to detect, confirm, and monitor TB and drug resistance. While the excerpted notice does not provide a detailed scope of work or required activities, the title and the CDC center involved strongly indicate continued support for public health TB prevention and control efforts and the laboratory functions that underpin those efforts, such as testing, quality assurance, reporting, and coordination with TB surveillance and case management systems. The cooperative agreement structure also signals that recipients are typically expected to work in close partnership with CDC program staff to meet national TB elimination goals and performance expectations.
Administratively, the opportunity was posted and created on July 1, 2015, with an original and current closing date of August 31, 2015, and an archive date of September 30, 2015. The announcement indicates an expected 50 awards, consistent with a program that supports a broad network of public health jurisdictions or established grantees. It lists the CFDA number 93.116 (Project Grants and Cooperative Agreements for Tuberculosis Control Programs), and it specifies that there is no cost sharing or matching requirement. The funding fields in the provided record show zeros for estimated total funding, award ceiling, and award floor, which typically indicates those amounts were not populated in the summary record or vary by recipient under continuation funding rather than being competed as a new, fixed-dollar opportunity.
For applicants or current grantees needing help obtaining or viewing the full announcement, the CDC provides a point of contact through its procurement/grants office: CDC PGO at 770-488-2700 or via email at pgotim@cdc.gov.
Frequently Asked Questions (FAQs)
What is the name of this funding opportunity?
The opportunity is titled the Tuberculosis Elimination and Laboratory Cooperative Agreement.
What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is CDC RFA PS15-150102CONT16.
Which federal agency is offering this opportunity?
This is a Centers for Disease Control and Prevention (CDC) funding opportunity.
Which part of CDC administers the program?
It is administered through the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention.
What type of funding instrument is being used?
The funding instrument is a cooperative agreement.
What does "cooperative agreement" mean in this context?
Based on the description provided, a cooperative agreement generally means CDC expects substantial involvement with recipients in carrying out the work, such as collaboration, technical guidance, shared planning, or coordinated implementation (as opposed to a more hands-off grant).
Is this a new competitive grant or continuation funding?
This announcement is explicitly a continuation of funds tied to the earlier opportunity PS15-1501 ("Tuberculosis Elimination and Laboratory Cooperative Agreement").
Who is eligible to apply?
The eligible applicant pool is restricted. It is intended only for organizations that were already funded under PS15-1501 and are continuing the same CDC-supported TB elimination and laboratory activities.
The listing says "Others" are eligible. Can a new organization apply?
Even though the listing shows eligible applicants as "Others (see text field entitled Additional Information on Eligibility for clarification)," the eligibility statement provided indicates that new applicants are not the target for this continuation action. The continuation is intended for organizations previously funded under PS15-1501.
What program area or category does this opportunity fall under?
It sits within the health funding activity category.
What is the overall purpose or focus of the program?
It aligns with CDC's public health mission in tuberculosis (TB) control and elimination, including the laboratory capacity needed to detect, confirm, and monitor TB and drug resistance.
Does the notice provide a detailed scope of work or required activities?
The excerpted notice does not provide a detailed scope of work or list of required activities. However, the title and CDC center involved indicate continued support for TB elimination and the laboratory functions that underpin TB prevention and control.
What kinds of laboratory-related activities are implied by the description?
Based on the description provided, the supported laboratory functions may include activities such as testing, quality assurance, reporting, and coordination with TB surveillance and case management systems, as well as efforts related to monitoring drug resistance.
How many awards are expected?
The announcement indicates an expected 50 awards.
What is the CFDA number associated with this opportunity?
The CFDA number listed is 93.116, described as "Project Grants and Cooperative Agreements for Tuberculosis Control Programs."
Is there a cost sharing or matching requirement?
No. The announcement specifies there is no cost sharing or matching requirement.
What are the posted and closing dates for this opportunity?
It was posted and created on July 1, 2015. The original and current closing date is August 31, 2015.
What is the archive date?
The archive date listed is September 30, 2015.
Why do the funding fields show $0 for total funding, ceiling, and floor?
The provided record shows zeros for estimated total funding, award ceiling, and award floor. The description indicates this typically means the amounts were not populated in the summary record or may vary by recipient under continuation funding rather than being presented as a new, fixed-dollar competitive opportunity.
Who can be contacted for help obtaining or viewing the full announcement?
The CDC point of contact listed is the CDC PGO (procurement/grants office) at 770-488-2700 or by email at pgotim@cdc.gov.
What does the continuation relationship mean for recipients?
Based on the information provided, the continuation relationship means the funding is tied to the earlier opportunity PS15-1501 and is intended to support the continued CDC-supported TB elimination and laboratory activities of existing recipients, with CDC involvement consistent with a cooperative agreement.
Browse more opportunities from the same agency: Centers for Disease Control and Prevention
Browse more opportunities from the same category: Health
Next opportunity: FY15 Countermeasures to Reduce Suicides on Railroad Rights of Way
Previous opportunity: Data Collection for Refuge Impoundment Hydrodynamic Modeling
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA PS15 150102CONT16
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA PS15 150102CONT16) also looked into and applied for these:
| Funding Opportunity |
|---|
| Accelerating the Prevention and Control of HIV/AIDS, Viral Hepatitis, STDs and TB in the U.S. Affiliated Pacific Islands Apply for CDC RFA PS13 130104CONT16 Funding Number: CDC RFA PS13 130104CONT16 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| The Biomedical Advanced Research and Development Authority Special Projects Apply for EP IDS 15 002 Funding Number: EP IDS 15 002 Agency: Assistant Secretary for Preparedness and Response Category: Health Funding Amount: $200,000 |
| International Research Scientist Development Award (IRSDA) (K01) Apply for PAR 15 291 Funding Number: PAR 15 291 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Aging Research to Address Health Disparities (Admin Supp) Apply for PA 15 293 Funding Number: PA 15 293 Agency: National Institutes of Health Category: Health Funding Amount: $45,000 |
| Tuberculosis Regional Training and Medical Consultation Centers Apply for CDC RFA PS13 130404CONT16 Funding Number: CDC RFA PS13 130404CONT16 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Limited Competition Consortia for HIV/AIDS and Alcohol Related Research Trials (CHAART) Project (Collaborative U01) Apply for RFA AA 16 001 Funding Number: RFA AA 16 001 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Limited Competition Consortia for HIV/AIDS and Alcohol Related Research Trials (CHAART) Resource Core (U24) Apply for RFA AA 16 003 Funding Number: RFA AA 16 003 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Limited Competition Consortia for HIV/AIDS and Alcohol Related Research Trials (CHAART) Administrative Resource Core (U24) Apply for RFA AA 16 002 Funding Number: RFA AA 16 002 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Smallpox Research Oversight ActivitiesWHO Advisory Committee on Variola Virus Research Apply for EP IDS 15 003 Funding Number: EP IDS 15 003 Agency: Assistant Secretary for Preparedness and Response Category: Health Funding Amount: $315,000 |
| Claude D. Pepper Older Americans Independence Centers (P30) Apply for RFA AG 16 011 Funding Number: RFA AG 16 011 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Screening and Brief Alcohol Interventions in Underage and Young Adult Populations (R01) Apply for PA 15 295 Funding Number: PA 15 295 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| AHRQ Patient Centered Outcomes Research Clinical Decision Support Learning Network (U18) Apply for RFA HS 15 003 Funding Number: RFA HS 15 003 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $500,000 |
| Healthy Parks, Healthy People Apply for P15AS00202 Funding Number: P15AS00202 Agency: National Park Service Category: Health Funding Amount: $100,000 |
| Screening and Brief Alcohol Interventions in Underage and Young Adult Populations (R03) Apply for PA 15 296 Funding Number: PA 15 296 Agency: National Institutes of Health Category: Health Funding Amount: $50,000 |
| Screening and Brief Alcohol Interventions in Underage and Young Adult Populations (R21) Apply for PA 15 294 Funding Number: PA 15 294 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| National Indian Health Outreach and Education, Policy/Budget/Diabetes Apply for HHS 2015 IHS NIHOE 1 PBD 0003 Funding Number: HHS 2015 IHS NIHOE 1 PBD 0003 Agency: Indian Health Service Category: Health Funding Amount: $825,000 |
| Caring for Children and Empowering Young People (C2EYP) Apply for RFA 621 15 00005 Funding Number: RFA 621 15 00005 Agency: Tanzania USAID Dar es Salaam Category: Health Funding Amount: $65,000,000 |
| PPHF 2015 Tobacco Quitlines A Comprehensive Approach to Good Health and Wellness in Indian Country financed solely by 2015 Prevention and Public Health Funds Apply for CDC RFA DP14 14210201SUPP15 Funding Number: CDC RFA DP14 14210201SUPP15 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $150,000 |
| Facile Methods and Technologies for Synthesis of Biomedically Relevant Carbohydrates (U01) Apply for RFA RM 15 007 Funding Number: RFA RM 15 007 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| NINDS Research Program Award (R35) Apply for RFA NS 16 001 Funding Number: RFA NS 16 001 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA PS15 150102CONT16", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.